Intermediate for Efinaconazole. Efinaconazole (trade names: Jublia and Clenafin) is a 14α-demethylase inhibitor for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole has been approved by the U.S Food and Drug Administration on June 6, 2014.
Product Name: (2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol
CAS Number: 133775-25-4
Molecular Weight:  269.2504
Molecular Formula:  C12H13F2N3O2
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.